Lido Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.3M | Buy |
33,950
+133
| +0.4% | +$16.8K | 0.02% | 386 |
|
2025
Q1 | $4.33M | Buy |
33,817
+1,580
| +5% | +$202K | 0.02% | 356 |
|
2024
Q4 | $4.26M | Sell |
32,237
-3,786
| -11% | -$501K | 0.02% | 337 |
|
2024
Q3 | $5.25M | Sell |
36,023
-4,336
| -11% | -$631K | 0.03% | 281 |
|
2024
Q2 | $5.54M | Buy |
40,359
+907
| +2% | +$124K | 0.03% | 256 |
|
2024
Q1 | $5.41M | Buy |
39,452
+968
| +3% | +$133K | 0.03% | 256 |
|
2023
Q4 | $5.23M | Buy |
38,484
+1,340
| +4% | +$182K | 0.04% | 243 |
|
2023
Q3 | $4.54M | Buy |
37,144
+1,769
| +5% | +$216K | 0.03% | 245 |
|
2023
Q2 | $4.49M | Buy |
35,375
+2,662
| +8% | +$338K | 0.03% | 227 |
|
2023
Q1 | $4.23M | Buy |
32,713
+312
| +1% | +$40.3K | 0.04% | 216 |
|
2022
Q4 | $4.25M | Buy |
32,401
+1,073
| +3% | +$141K | 0.05% | 176 |
|
2022
Q3 | $3.66M | Buy |
31,328
+1,330
| +4% | +$156K | 0.05% | 166 |
|
2022
Q2 | $3.53M | Sell |
29,998
-379
| -1% | -$44.6K | 0.05% | 147 |
|
2022
Q1 | $3.96M | Sell |
30,377
-1,185
| -4% | -$154K | 0.04% | 154 |
|
2021
Q4 | $4.82M | Buy |
31,562
+3,935
| +14% | +$600K | 0.05% | 152 |
|
2021
Q3 | $4.47M | Buy |
27,627
+4,574
| +20% | +$739K | 0.06% | 151 |
|
2021
Q2 | $3.77M | Buy |
23,053
+3,142
| +16% | +$514K | 0.05% | 158 |
|
2021
Q1 | $3M | Buy |
19,911
+1,345
| +7% | +$203K | 0.05% | 162 |
|
2020
Q4 | $2.81M | Sell |
18,566
-841
| -4% | -$127K | 0.06% | 158 |
|
2020
Q3 | $2.63M | Buy |
19,407
+814
| +4% | +$110K | 0.07% | 130 |
|
2020
Q2 | $2.54M | Buy |
18,593
+1,673
| +10% | +$229K | 0.08% | 122 |
|
2020
Q1 | $1.82M | Sell |
16,920
-1,408
| -8% | -$152K | 0.08% | 127 |
|
2019
Q4 | $2.21M | Buy |
18,328
+2,827
| +18% | +$341K | 0.09% | 115 |
|
2019
Q3 | $1.54M | Buy |
15,501
+494
| +3% | +$49.1K | 0.08% | 133 |
|
2019
Q2 | $1.64M | Buy |
15,007
+142
| +1% | +$15.5K | 0.09% | 117 |
|
2019
Q1 | $1.66M | Buy |
14,865
+9,435
| +174% | +$1.05M | 0.11% | 111 |
|
2018
Q4 | $523K | Buy |
5,430
+1,174
| +28% | +$113K | 0.05% | 202 |
|
2018
Q3 | $519K | Buy |
4,256
+875
| +26% | +$107K | 0.05% | 218 |
|
2018
Q2 | $371K | Buy |
3,381
+585
| +21% | +$64.2K | 0.04% | 250 |
|
2018
Q1 | $298K | Buy |
2,796
+437
| +19% | +$46.6K | 0.04% | 269 |
|
2017
Q4 | $251K | Buy |
2,359
+157
| +7% | +$16.7K | 0.04% | 242 |
|
2017
Q3 | $230K | Buy |
+2,202
| New | +$230K | 0.04% | 235 |
|